Integration of Biosimilars in the management of Lymphoma

Description

Case Presentation followed by a didactic lecture. 50 year old sero-reactive female on HAART since 2006, diagnosed with Hodgkinâ??s lymphoma stage II B in June 2020, after presenting with neck and axillary swellings, and B symptoms for 3 months. She was started on chemotherapy (ABVD) regimen which she completed 6 cycles in February 2021 with good clinical and radiological response. Currently on 3 monthly reviews

Objectives

Presenters

1. Dr. Hildah Kaziga
   Oncology General Practitioner
   International Cancer Institute